Suppr超能文献

散发性微卫星高度不稳定胃癌中hMLH1启动子甲基化但无hMLH1突变

Methylation of the hMLH1 promoter but no hMLH1 mutations in sporadic gastric carcinomas with high-level microsatellite instability.

作者信息

Bevilacqua R A, Simpson A J

机构信息

Laboratory of Cancer Genetics, Ludwig Institute for Cancer Research, São Paulo, Brazil.

出版信息

Int J Cancer. 2000 Jul 15;87(2):200-3. doi: 10.1002/1097-0215(20000715)87:2<200::aid-ijc7>3.0.co;2-i.

Abstract

Microsatellite instability (MSI) in tumors from patients with hereditary non-polyposis colorectal cancer (HNPCC) is caused by germline mutations in mismatch repair (MMR) genes, principally hMSH2 and hMLH1. In contrast, somatic mutations in MMR genes are relatively rare in sporadic MSI(+) colon cancers. Rather, the majority of mutation-negative, MSI(+) cases involve hypermethylation of the hMLH1 promoter and subsequent lack of expression of hMLH1. The details of the mechanisms of this epigenetic gene silencing remain to be elucidated. In some colon cancer cell lines, hMLH1 promoter methylation is accompanied by mutation of 1 of the 2 alleles, whereas in other cell lines and tumors, such combinations have not been reported. To contribute to the characterization of MSI in gastric cancer and to directly investigate whether hMLH1 promoter methylation is accompanied by gene mutation in these cancers, we have analyzed 42 gastric tumors and corresponding normal tissue for MSI, hypermethylation of the hMLH1 promoter, and mutations in hMLH1 as well as hMSH2. We found that 10 (23.8%) of 42 cases of sporadic gastric cancer were MSI(+) and that 8 had at least 2 of 12 altered microsatellite loci. All samples with at least 2 altered loci exhibited methylation of the hMLH1 promoter region, but none had detectable mutations in hMLH1 or hMSH2. Our results confirm the importance of methylation of the hMLH1 promoter region in MSI(+) gastric tumors and suggest that methylation takes place in the absence of hMLH1 mutations in these tumors.

摘要

遗传性非息肉病性结直肠癌(HNPCC)患者肿瘤中的微卫星不稳定性(MSI)是由错配修复(MMR)基因的种系突变引起的,主要是hMSH2和hMLH1。相比之下,MMR基因的体细胞突变在散发性MSI(+)结肠癌中相对少见。相反,大多数突变阴性、MSI(+)病例涉及hMLH1启动子的高甲基化以及随后hMLH1表达的缺失。这种表观遗传基因沉默的机制细节仍有待阐明。在一些结肠癌细胞系中,hMLH1启动子甲基化伴随着两个等位基因之一的突变,而在其他细胞系和肿瘤中,尚未报道这种组合情况。为了有助于表征胃癌中的MSI,并直接研究这些癌症中hMLH1启动子甲基化是否伴随着基因突变,我们分析了42例胃肿瘤及其相应的正常组织的MSI、hMLH1启动子的高甲基化以及hMLH1和hMSH2的突变情况。我们发现,42例散发性胃癌中有10例(23.8%)为MSI(+),其中8例在12个改变的微卫星位点中至少有2个发生改变。所有至少有2个改变位点的样本均显示hMLH1启动子区域甲基化,但hMLH1或hMSH2均未检测到突变。我们的结果证实了hMLH1启动子区域甲基化在MSI(+)胃肿瘤中的重要性,并表明这些肿瘤中甲基化发生在hMLH1无突变的情况下。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验